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MEETING REPORT Open Access
Mentoring future Kenyan oncology researchers
Ann Moormann1*†, Jodi Skiles2*†, Emmanuel Koros3, Fredrick Chite Asirwa2,3, Naftali Busakhala3,4
and Patrick Loehrer2
Abstract
This is a summary of the 1st Academic Model Providing Access to Healthcare (AMPATH) Oncology Institute research
grant writing workshop organized in collaboration with the Kenya Medical Research Institute (KEMRI) and held in
Kisumu, Kenya from January 16th to 18th, 2013. The goal of this meeting was to mentor future Kenyan scientists and
prioritize research topics that would lead to improved cancer care and survival for the citizens of Kenya.
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Introduction
Medical Scientists drawn from the Academic Model
Providing Access to Healthcare (AMPATH) Consortium
collaborated with the Kenya Medical Research Institute
(KEMRI) in Kisumu to host the first United States,
National Cancer Institue (NCI) sponsored oncology-
focused grant writing workshop. The goal of this work-
shop was to mentor health care researchers and to
prioritize research topics that could lead to improved
cancer care and survival for the citizens of Kenya. The
spectrum of cancer research included prevention, early
detection and screening as well as palliative care. Twenty
mentees out of 34 applicants were selected through a
competitive process in which submitted applications were
reviewed based on research interests, how those interests
could improve cancer care and outcomes, and how this
training would facilitate their careers in medical research.
Ideas for research proposals were stimulated by a series of
Provocative Questions given to applicants prior to the
meeting (Appendix 1).
Kenya, like much of the developing world, is rapidly
undergoing an ‘epidemiologic transition’ from a health
scene dominated by infectious diseases to one in which
the chronic diseases such as cancer are becoming major
causes of death and disability. Under these circum-
stances, applying science to the management and control
of cancer has become as relevant to Kenya as it is in the
United States and other countries. Cancer research in
Kenya, whose population is the most genetically diverse
in the world [1], will catalyze the discovery of new genes
of importance in the fight against cancer, new genomic
predictors of cancer, and new genetic variants that pre-
dict response to therapy. AMPATH Oncology Institute
(AOI) activities aim to directly contribute to advances in
cancer care and accelerate discoveries in the biology and
treatment of cancer in Kenya. One of the most impor-
tant components of this mission is training Kenyan
scientists and strengthening the collaborative research
environment.
The AMPATH consortium
AMPATH stands for the Academic Model for Provi-
ding Access to Healthcare (AMPATH: http://www.
ampathkenya.org/). AMPATH opened its first clinics
in 2001, at a time in which the AIDS epidemic domi-
nated the health landscape of sub-Saharan Africa. The
AMPATH model is a partnership between Moi University
School of Medicine (MUSOM), Moi Teaching and
Referral Hospital (MTRH, Kenya’s second national referral
hospital), and a consortium of U.S. and Canadian medical
schools led by Indiana University School of Medicine.
North American AMPATH consortium partners also
include the Alpert Medical School of Brown University,
Hubert-Yeargan Center for Global Health at Duke
University Medical Center, Lehigh Valley Health Net-
work of Pennsylvania, Eck Institute for Global Health at
Notre Dame University, Providence Portland Medical
Center, Purdue University, University of Massachusetts
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Medical School, University of Utah School of Medicine and
University of Toronto Faculty of Medicine. Institutions par-
ticipating in the AMPATH Consortium engage in student
and faculty exchange, clinical care, training, and research,
all essential for successfully addressing the short- and long-
term challenges of global health. While training and re-
search are critically important to the program, AMPATH
has always been determined to “lead with care.” Care is not
only the most pressing obligation when faced with the
needs of an under-served population, it is also the founda-
tion upon which training and research is conducted.
Some of our newer programs focus on chronic diseases
such as cancer. Within this context, AMPATH is creating
a Center of Excellence in Cancer Care with the naming of
the AMPATH Oncology Institute (AOI). The goal of AOI
is to be the premier cancer program in Sub-Saharan
Africa, noted for excellence in cancer research, prevention,
treatment and palliative care. And in order to meet this
need, specialized training in oncology and oncology-
related research is imperative.
AOI research grant writing workshop
A three-day symposium was conducted from January
16th to 18th, 2013 in Kisumu, Kenya which included doc-
tors, nurses and other health-allied scientists affiliated
with the Hemato-Oncology Department at the MTRH
and AMPATH Oncology, located in Eldoret. Faculty
mentors from the United States and Kenya dedicated
three days to teaching participants about writing grant
proposals for conducting research in oncology.
The most prevalent cancers seen at AOI are listed in
Table 1. In 2012, doctors at AOI saw over 800 newly
diagnosed cancer patients resulting in over 4000 cumu-
lative patient visits during the course of the year for
oncology-related matters and the administration of over
3500 cycles of chemotherapy. Some of these appoint-
ments consisted of follow-up care and monitoring that
did not require treatment, however the increasing
number of diagnosed patients endorses the need for an
equally increasing number of trained oncologists and
support staff. Screening for breast and cervical cancer
has also become an important service to the community.
MTRH-AMPATH alone screened over 7000 women in
2012. Recognizing cancer as a priority health concern in
Kenya, the IU Simon Cancer Center (IUSCC) and the
AMPATH Program have been actively pursuing resources
to respond. We have found that some patients are unable
to complete the full course of treatment due to late stage at
time of diagnosis resulting in immediate referral to palliative
care. Financial burden placed on the family can also result
in abandonment of care. Therefore socio-economic issues
leading to poor compliance are also important topics for re-
search. The overall focus of the partnership is to develop a
sustainable and comprehensive academic clinical care pro-
gram that will serve the citizens of western Kenya. MTRH
currently has five formally trained medical Oncologists, six
Pathologists and two radiotherapy machines intended to
serve the entire country. Enhancing the clinical capacity
will also establish a solid foundation upon which im-
portant research questions can be investigated.
The workshop was chaired by Drs. Ann Moormann and
Jodi Skiles. Presenters at the workshop included Prof.
Thomas Inui (Indiana University School of Medicine, USA),
who provided an overview of grant writing and how import-
ant it is to learn how to convey your research ideas, objec-
tives and desired outcomes. Clearly explaining how research
can translate into better care and survival for patients is an
important aspect of successfully funded grant proposals.
Dr. Stephen Munga (KEMRI-Centre for Global Health
Research, Kenya) followed with a talk on “Conducting
Health Services Research in Low Income Countries.” He
stressed the importance of understanding local and
regional determinants of health, knowledge of ongoing
health research efforts – including how social factors such
as family, community, and the central government play a
role in contributing to health and health behaviors. He
further emphasized that limited resources, inadequate in-
frastructure, the effects of “brain drain” and limited com-
munication between researchers and policy makers pose
great challenges to researchers in developing countries.
Prof. Patrick Loehrer (Director of the IUSCC and the
AOI), covered the basic tenets of writing a clinical trial.
Another important aspect of entering into the research
arena was presented by Prof. Anthony Mega (Alpert
Medical School at Brown University, USA) who deliv-
ered a lecture titled: “Mentorship: the art of choosing,
using and becoming a mentor.” Mega said that a mentor
should be a role model, an advisor, an encourager, a re-
source person, a counselor, sponsor and a friend. They
ought to inspire, support and invest in their mentees.
Research is often a team endeavor whereby scientists
with different strengths bring their expertise to the table.
Another key topic of interest “Integrating Transla-
tional Research into Clinical Research” was introduced
by Prof. Alan Rosmarin (University of Massachusetts
Medical School, USA). He opened the discussion by
Table 1 Prevalent cancers at AOI 2001-2011
Diagnosis No. of cases
Kaposi’s sarcoma 1161
Cancer of esophagus 998
Cancer of cervix 856
Leukemia 789
Breast cancer 748
NHL/Burkitt lymphoma 748
Prostate cancer 482
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posing a question to participants about what barriers
exist to implementing translational research in Kenya.
The participants cited limited availability of laboratory
technology available, academic silos within the govern-
ment, and a lack of access to care for all citizens.
While delivering a talk on Manuscript Writing, Prof.
Ann Moormann (University of Massachusetts Medical
School, USA) emphasized that upon getting results, the re-
searcher must strive to tell their target audience what those
results mean by interpreting the data and explaining how
those results add to what is already known about the topic.
Writing the manuscript should take high priority because
it is the end product of research efforts and adds to the
body of knowledge within the medical community. An-
other salient point highlighted was that publication costs
for scientists in resource-limited settings may be waived or
greatly reduced by many journals. She also mentioned the
value of publishing in open-access journals which are avail-
able to your colleagues without a subscription fee.
Other presenters included Prof. Edwin Were (Moi Univer-
sity, Kenya), who delivered a lecture on ethical considerations
for conducting research in resource-constrained settings and
Dr. Christine Wasunna, (KEMRI, Kenya) who gave a talk on
cultural considerations in community-based cancer research
in Kenya. David Mulama, (KEMRI, Kenya), presented a brief
tutorial on data management and analysis, mentioning statis-
tical programs that are often available as open source soft-
ware. Prof. Greg Gramelspacher (Indiana University School
of Medicine, USA) shared his experience on palliative care
research in low and middle-income countries. Providing
comfort and relieving suffering for those diagnosed with can-
cer is a critically important aspect of cancer care.
The morning presentations were followed by after-
noon small group sessions where four to five mentees
worked directly with two to three mentors. These ses-
sions allowed the mentees to ask more specific questions
about their research proposals and seek feedback from
their peers. The evenings were free time for the mentees
to work on their project presentations.
The peer-review process
The workshop format included short (10–15 minute) in-
dividual research proposal presentations from each of
the mentees. After each participant presented their
work, the proposals underwent a peer-review process.
The three best proposals were selected by the other par-
ticipants and given special recognition. This process was
to simulate peer-review for grant applications whereby
only the best proposals get selected for funding. This
also allowed the mentees to understand how they could
improve their research proposal by integrating con-
structive suggestions into their revisions.
The concluding presentation was an inspiring talk by
Dr. Kirtika Patel (Moi University, Kenya) who gave a
brief overview of her research journey covering the key
elements of making the transition from mentee to men-
tor. She urged the future researchers to exercise patience
when writing their proposals, bearing in mind that per-
sistence is a critical key to success.
Future directions
The long-term goal of this workshop is to continue to
strengthen research partnerships between collaborators
from various institutions that can be leveraged to apply
for grant applications. This is being accomplished by con-
tinued mentor-mentee communication via the internet
and weekly conference calls, helping to identify requests
for grant applications that would be amenable to the situ-
ation in Kenya, and ongoing grant writing mentorship.
Appendix 1
Provocative Research Questions
Breast Cancer
 Is breast cancer in Kenya different from North
American patient populations?
 Why do younger women get breast cancer in
Sub-Saharan Africa?
 What obstacles to early detection of breast cancer
can be overcome in Kenya?
 How effective is standard chemotherapy or hormonal
therapy in breast cancer in Kenyan women?
 Are there associated risk factors for breast cancer
in women of Kenya?
Cervical Cancer
 What are the Human Papillomavirus (HPV) serotypes
for cervical cancer in Kenya?
 What is the impact of antiretrovirals in patients
diagnosed with and treated for cervical cancer?
 Is single agent chemotherapy effective in advanced
cervical cancer?
 Are there regional differences in incidence and
outcome of cervical cancer?
Lymphoma
 What are the most common histologies of non-
Hodgkin lymphoma (NHL) in western Kenya?
 How accurate is histologic identification of NHL in
Kenya?
 Will improved subclassification of NHL improve
outcomes of lymphoma therapy in Kenya?
 What is the safest and most effective treatment for
NHL in resource constrained setting?
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Palliative & Supportive Care
 What is the scope of pain management in Kenya
and what opportunities exist to enhance it?
 Do vitamin (e.g., folate) supplements improve
outcome when combined with chemotherapy?
 What are public perception and beliefs of cancer?
 What are obstacles to vaccine therapy in adolescent
girls and boys in Kenya?
 Can a culturally appropriate model to end-of-life
communication be developed and implemented in
western Kenya?
Kaposi Sarcoma
 Why is Kaposi sarcoma (KS) more prevalent in
Kenya compared to US?
 Why is severity and extent of KS worse in Kenya?
 Can optimization of dermatologic care improve
palliation of KS patients?
 Is there a drug-drug interaction with antiretroviral
therapy and chemotherapy in patients with KS?
Pediatric Oncology
 Is acute lymphoblastic leukemia (ALL) different based
on cell phenotype or cytogenetics in Kenya patients
compared to children in North America (NA)?
 Is Wilm’s tumor in Kenya different compared to
NA by protein profiling?
 What obstacles to early detection of leukemia/
lymphoma can be overcome in Kenya?
 How effective is standard chemotherapy in ALL?
 Is it feasible to utilize flow cytometry for the
diagnosis of leukemia and lymphoma in Kenya?
 What is the impact of antiretroviral therapy in
patients diagnosed with NHL/Burkitt’s?
 Are there regional/ethnic differences in incidence
and outcome of leukemia?
 What are the most common histologies of pediatric
NHL in western Kenya?
 How accurate is histologic identification of
pediatric NHL in Kenya?
 What is the safest and most effective treatment for
pediatric NHL and ALL in a resource-limited setting?
 What are the factors that contribute to abandonment
of care in pediatric oncology patients in Kenya – and
are they different than those seen in adults?
 How can pediatric cancers (specifically leukemia,
NHL, Wilm’s, and retinoblastoma) be identified and
referred earlier for care?
 Can a cost-effective sustainable model for cancer
care be established in Kenya?
 Why is there such a discrepancy in survival
between pediatric ALL patients in North America
and Kenya?
 What are the main causes of mortality in the
context of therapy for pediatric malignancies?
Health behavior, health education topics
 Why do many patients with potentially preventable
conditions fail to present for cancer screening
services within the AMPATH system of care.
 Corollary question: Why do some AOI patients in
care for malignancies drop out of care?
Other topics
 What are the Human Papilloma Virus (HPV)
serotypes in head and neck cancer in Kenya?
 What is prevalence of smoking and exposure to smoke
(homes) in Kenya and association with cancers?
 Can a cost-effective sustainable model for cancer
care be established in Kenya?
 What is the impact of economic barriers (perceived
or real) in seeking and sustaining cancer care?
 What financing model (i.e. sliding-fee scale) is
appropriate in Kenya?
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